
Xenetic Biosciences
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $725 | $660 | $806 | $766 |
Gross Profit | -1,739 | 660 | 806 | 766 |
EBITDA | -1,695 | -929 | -456 | -579 |
EBIT | -971 | -502 | -623 | |
Net Income | -1,695 | -929 | -456 | -579 |
Net Change In Cash | 725 | 660 | 806 | 766 |
Free Cash Flow | -662 | -875 | -536 | -242 |
Cash | 5,809 | 6,471 | 7,347 | 7,883 |
Basic Shares | 2,343 | 2,294 | 2,291 | 2,291 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,976 | $2,500 | $2,539 | $1,706 |
Gross Profit | 2,976 | 2,500 | 2,539 | 1,706 |
EBITDA | -2,680 | -3,806 | -4,134 | -6,525 |
EBIT | -2,834 | -3,960 | -4,487 | -6,552 |
Net Income | -2,680 | -3,960 | -4,134 | -6,552 |
Net Change In Cash | 2,976 | 2,500 | 2,539 | 1,706 |
Free Cash Flow | -2,286 | -2,817 | -4,114 | -5,146 |
Cash | 7,883 | 6,165 | 8,983 | 13,097 |
Basic Shares | 1,701 | 1,541 | 1,528 | 1,422 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.72 |
2026-06-30 | -$0.41 |
2026-03-31 | -$0.19 |
2025-12-31 | -$0.22 |